Healthcare Consulting Clinical Research Industry Analysis
US Stocks: Rocket Pharma shares fall 15% despite FDA nod for childhood disorder treatment
FDA approval paradox: Rocket Pharma gene therapy success masks commercialization risks, signaling challenges for rare disease biotech sector globally and in India's emerging biotech ecosystem.
Impact: 4/10